Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Findlay

Showing results (161-170 of 170) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 170 results.
Advances in Cancer Research|April 4, 2020
BMI, physical activity, and breast cancer subtype in white, black, and Sea Island breast cancer survivorsMarvella E Ford, Colleen E Bauza, Victoria J Findlay, et al.
Frontiers in Immunology|January 26, 2026
Making deep immunophenotyping accessible: the successful application of a guided 23-parameter mouse immunophenotyping panel package provided through a shared resourceMadison G Isbell, Alex Wendling, Xinyan Pei, et al.
Breast Cancer Research and Treatment|October 29, 2018
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle interventionKatherine R Walter, Marvella E Ford, Mathew J Gregoski, et al.
Science Signaling|March 28, 2023
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapiesZacary P Germon, Jonathan R Sillar, Abdul Mannan, et al.
The British Journal of Surgery|May 11, 2021
Patient-reported outcomes after oesophagectomy in the multicentre LASER studyS R Markar, V Sounderajah, A Johar, et al.
Nature Genetics|December 5, 2022
The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and locationIlon Liu, Li Jiang, Erik R Samuelsson, et al.
Cancer Research|May 5, 2023
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline gliomaEvangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Cancer Research|May 17, 2023
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline GliomaEvangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Nature Communications|January 5, 2021
Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunityKathryn A Ryan, Kevin R Bewley, Susan A Fotheringham, et al.
The Journal of Clinical Investigation|February 6, 2024
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine gliomaRyan J Duchatel, Evangeline R Jackson, Sarah G Parackal, et al.
Pageof 17

Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
Advances in Cancer Research|April 4, 2020
BMI, physical activity, and breast cancer subtype in white, black, and Sea Island breast cancer survivorsMarvella E Ford, Colleen E Bauza, Victoria J Findlay, et al.
Frontiers in Immunology|January 26, 2026
Making deep immunophenotyping accessible: the successful application of a guided 23-parameter mouse immunophenotyping panel package provided through a shared resourceMadison G Isbell, Alex Wendling, Xinyan Pei, et al.
Breast Cancer Research and Treatment|October 29, 2018
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle interventionKatherine R Walter, Marvella E Ford, Mathew J Gregoski, et al.
Science Signaling|March 28, 2023
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapiesZacary P Germon, Jonathan R Sillar, Abdul Mannan, et al.
The British Journal of Surgery|May 11, 2021
Patient-reported outcomes after oesophagectomy in the multicentre LASER studyS R Markar, V Sounderajah, A Johar, et al.
Nature Genetics|December 5, 2022
The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and locationIlon Liu, Li Jiang, Erik R Samuelsson, et al.
Cancer Research|May 5, 2023
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline gliomaEvangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Cancer Research|May 17, 2023
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline GliomaEvangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Nature Communications|January 5, 2021
Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunityKathryn A Ryan, Kevin R Bewley, Susan A Fotheringham, et al.
The Journal of Clinical Investigation|February 6, 2024
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine gliomaRyan J Duchatel, Evangeline R Jackson, Sarah G Parackal, et al.
Pageof 17